Documents / Official release
This Defense Intelligence Reference Document, dated 31 March 2010 and numbered DIA-08-1003-020, was prepared by the Defense Intelligence Agency's Defense Warning Office under its Advanced Aerospace Weapon System Applications Program. It surveys biosensors and biomedical microelectromechanical systems, covering brain-implanted micromachine neuroelectrodes, drug-delivery pumps, glucose sensors, neural interfaces, retinal prostheses, microfluidic lab chips, NASA cell-culture systems and microcantilever sensors. It concludes that the field is expanding rapidly, with nanomechanical systems expected to follow.
From the source:Release of 2026-09-18 Incident: 3/31/10, Las Vegas, Nevada. Released with redactions. This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed. This DIRD surveys biosensors and BioMEMS, a broad class of miniature biomedical devices that combine microscale engineering with sensing, fluid handling, stimulation, or drug-delivery functions. The report reviews major application areas including implantable blood-chemistry sensors, neural interfaces, neurostimulation, drug-delivery pumps, microfluidic systems, and emerging nanoscale extensions of the field, while emphasizing that miniaturization can improve sensitivity and enable functions that are difficult or impossible at larger scales. However, it also makes clear that practical development is constrained by biocompatibility, long-term stability, sensor drift, device degradation inside the body, and the high regulatory burden associated with implantable medical systems. The document presents BioMEMS as a rapidly growing and productive field whose future advances are likely to come through continued improvements in fabrication, materials, and reliability.
UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
move through the channels where processes of separation, filtering, mixing, heating,
reaction, and waste disposal can occur in a programmed sequence . Color changes after
a sequence of chemica l steps might be used to ind icate the presence and concentration
of an analyte. Optical absorbance or transparency can be read by a simple light
emitting diode (LED) and photodetector system that measures light passing through the
glass sample cell.
LAB CHIPS
A class of microfluidic devices known as lab-chips or Lab-on-a-Chip (LOC) have made
their appearance in the market place. These devices are miniature chemical analysis
systems that replace many of the manual and laborious steps associated with analytical
chemistry. They are generally produced by MEMS techniques and often, but not always,
incorporate electrical systems on the devices.
Automated MEMS-based lab-on-a-chip platforms have become an established system
for basic life science research and drug discovery. They are used to assess the
characteristics of isolated DNA or proteins.
One of the most useful products of bioMEMS instrumentation is the ability to manipulate
small quantities of DNA using microfluidic pathways to perform chemistry with only the
content from a sing le cell. BioMEMs enable new techniques in genomics (the study of
sets of genes, gene products, and their interactions) and proteomics (the study of
proteins, the expression of genes in health and disease).
These systems are bei ng made now by companies including Affymetix, Caliper,
Nanogen, and Agilent for processing samples on a microfluidic chip for separation and
detection. Figure 31 shows the variety of such systems currently on the market.
Such devices can replace a number of gel electrophoresis operations and substantially
improve work flow sample handling and analysis, lower per sample analysis by 10X and
minimize sample and reagent use.
The physics of these microfluidic systems enable some unique features, including
smooth laminar flow t hrough the microchannels, high surface area to volume ratios,
small thermal mass, and strong effects by electric fields. Microfluidic devices also lend
themselves to enhancements for single cell detection, fluorescence detection, sorting
schemes, and unique fluid separation methods.
The advantages of lab-on-chip devices include:
• Improved fluid transport by electrokinetic effects and miniaturized pumps.
• Efficient molecular and particle separation and immobilization.
• Smaller sample requirements and carrier volumes.
• Reduced reagent consumption and expense.
• Integration of channels, mixers, separators, reaction chambers, electrodes, and
detectors into single devices.
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
33 Not linked to a story yet.
Official release, from the pursue collection. The PDF is mirrored here; the original link is above. 45 pages are in the text index: search them above, or from the library's search.